Drug Database
Back to search

France· FR:65436166

TRASYLOL 500 000 UIK/50 mL, solution injectable

A aprotinin product containing aprotinine, registered in France by NORDIC GROUP (PAYS-BAS). The same ATC class is registered in 11 of our 19 countries.

ATC B02AB01

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedTRASYLOL 500 000 UIK/50 mL, solution …ATCB02AB01REGISTER NO.FR:65436166PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about aprotinineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Aprotinin is registered in 11 of 19 countries.

Countries holding a registration under ATC B02AB01 (aprotinin), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 6 of them publish a price we can compare per daily dose
Search aprotinin products by name

Aprotinin · ATC B02AB01

11 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
APROTININE
Manufacturer
NORDIC GROUP (PAYS-BAS)
Country
France (FR)
ATC code
B02AB01
ATC class
Aprotinin
Defined daily dose
500 TSD, E
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400955722212
    1 flacon(s) en verre type I de 50 mL avec bouchon bromobutyle siliconé

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

6 interactions on record for aprotinin.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check aprotinin against other medicinesHow interaction checks work

Aprotinin · interactions on record

6 records

  • 3 severe
  • 3 moderate

Most severe, free to view

  • Faktor VIII-Inhibitor Bypass Aktivität - FEIBAB02BD03severe
  • TretinoinL01XF01severe
  • TretinoinL01XX14severe
  • AlteplaseB01AD02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Aprotinin in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All aprotinin products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Austria · Trasylol
  • Belgium · Trasylol
  • Germany · Trasylol
  • Denmark · Trasylol
  • Finland · Trasylol
  • United Kingdom (Northern Ireland) · Aprotinin
  • Hungary · Gordox
  • Ireland · Trasylol
  • Luxembourg · Trasylol
  • Netherlands · Trasylol
  • Poland · Trasylol
  • Portugal · Trasylol
  • Sweden · Trasylol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4dc94980-e55b-414d-bc22-3d731d46998f
GET /v1/drugs/4dc94980-e55b-414d-bc22-3d731d46998f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65436166",
  "date_amm": "1991-05-14",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "APROTININE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "intraveineuse;voie extracorporelle autre",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about aprotinin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console